31 – 40 of 265
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
MOSkin dosimetry for an ultra-high dose-rate, very high-energy electron irradiation environment at PEER
(
- Contribution to journal › Article
-
Mark
Stereotactic body radiotherapy as metastasis-directed therapy in oligometastatic prostate cancer: a systematic review and meta-analysis of randomized controlled trials
(
- Contribution to journal › Article
-
Mark
Probably Not!
(
- Contribution to journal › Letter
-
Mark
Register data on long-term morbidity after prostate ultra-hypofractionation in the HYPO-RT-PC trial
(
- Contribution to journal › Published meeting abstract
-
Mark
Impact of site-specific conjugation strategies on the pharmacokinetics of antibody conjugated radiotherapeutics
(
- Contribution to journal › Article
-
Mark
Has time to chemotherapy from primary debulking surgery in advanced ovarian cancer an impact on survival? - A population-based nationwide SweGCG study
(
- Contribution to journal › Article
-
Mark
In vivo MRI and PET imaging in a translational ILD mouse model expressing non-resolving fibrosis and bronchiectasis-like pathology after repeated systemic exposure to bleomycin
(
- Contribution to journal › Article
-
Mark
Register data on long-term morbidity after prostate cancer radiotherapy with ultra-hypofractionated (2.5 weeks) vs conventional (8 weeks) treatment schedules
2024) U21 Health Sciences Group 2024 Doctoral Student Forum(
- Contribution to conference › Poster
-
Mark
Anti-Müllerian hormone and fertility in women after childhood cancer treatment : Association with current infertility risk classifications
(
- Contribution to journal › Article
-
Mark
Investigating Ras homolog gene family member C (RhoC) and Ki67 expression following external beam radiation therapy show increased RhoC expression in relapsing prostate cancer xenografts
(
- Contribution to journal › Article